# The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases

> **NCT01785316** · PHASE3 · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 93 (actual)

## Conditions studied

- Melanoma
- Uveal Neoplasms

## Interventions

- **PROCEDURE:** IHP

## Key facts

- **NCT ID:** NCT01785316
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-15
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2024-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785316, "The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01785316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*